世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

泌尿器科治療の世界市場に関する洞察と2028年までの予測

泌尿器科治療の世界市場に関する洞察と2028年までの予測


Global Treatment for Genito-Urinary Market Insights and Forecast to 2028

尿路感染症治療の基本は、抗生物質です。抗生物質による治療は、存在する細菌の種類を判断し、適切な薬剤を選択することが必要です。尿路感染症の抗菌薬には、ナリジクス酸、ニトロフラントイン、オフロキサシン... もっと見る

 

 

出版社 出版年月 電子版価格 納期 言語
QYResearch
QYリサーチ
2022年2月18日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
5-7営業日 英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

尿路感染症治療の基本は、抗生物質です。抗生物質による治療は、存在する細菌の種類を判断し、適切な薬剤を選択することが必要です。尿路感染症の抗菌薬には、ナリジクス酸、ニトロフラントイン、オフロキサシン、ノルフロキサシン(複雑性尿路感染症用)などがあります。
市場の分析と洞察泌尿器科向け治療薬の世界市場
泌尿器科治療薬の世界市場規模は、2021年の100万米ドルから2028年には100万米ドルに達すると予測され、2022年から2028年の間にCAGR(年平均成長率)%で推移しています。
この健康危機による経済変化を十分に考慮し、2021年に泌尿器科向け治療の世界市場の%を占めたOTCは、2028年までに100万米ドルの値を付け、COVID-19後の期間に改訂された%のCAGRで成長すると予測されています。病院セグメントは、この予測期間を通して%CAGRに変更されている間。

2021年の中国の泌尿器科の治療市場規模は百万米ドル、北米と欧州の泌尿器科の治療はそれぞれ百万米ドル、百万米ドルとなっています。北米の割合は2021年に%、中国とヨーロッパはそれぞれ%、%で、中国の割合は2028年に%に達すると予測され、分析期間を通じてCAGRは%であることを追跡しています。日本、韓国、東南アジアはアジアで注目すべき市場であり、今後6年間のCAGRはそれぞれ%、%、%となっています。ヨーロッパの泌尿器系治療については、ドイツが2028年までに100万米ドルに達すると予測され、予測期間中のCAGRは%となっています。
本レポートは、業界標準の分析精度と高いデータ整合性により、世界の泌尿器科治療市場で利用可能な主要機会を明らかにし、プレイヤーが市場で確固たる地位を獲得するのに役立つような素晴らしい試みをしています。本レポートの購入者は、世界の泌尿器科治療市場の全体規模(売上高)など、検証済みで信頼できる市場予測にアクセスすることができます。

全体として、本レポートは、プレイヤーが競合他社に対する競争力を獲得し、世界の泌尿器科治療市場で永続的な成功を収めるために使用できる効果的なツールであることが証明されています。本レポートで提供されるすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証され、再確認されたものです。本レポートを執筆したアナリストは、世界の泌尿器科治療市場を詳細に調査するため、独自の業界最高水準の調査・分析アプローチを採用しています。

世界の泌尿器科治療薬の範囲と市場規模
泌尿器科治療市場は、プレイヤー別、地域別(国別)、タイプ別、用途別に分類されています。世界の泌尿器科向け治療法市場におけるプレイヤー、ステークホルダー、その他の参加者は、このレポートを強力なリソースとして利用することで、優位に立つことができるようになるでしょう。セグメント別分析では、2017年から2028年までのタイプ別およびアプリケーション別の収益と予測に焦点を当てます。

タイプ別セグメント
一般用医薬品
Rx医薬品
用途別セグメント
病院
ドラッグストア
その他

会社別
第一三共株式会社
ファイザー
バイエル
アステラス製薬
アラガン社
GSK
大塚製薬
サノフィ

地域別
北アメリカ
米国
カナダ
欧州
ドイツ
フランス
イギリス
イタリア
ロシア
北欧諸国
その他の欧州地域
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア
ラテンアメリカ
メキシコ
ブラジル
ラテンアメリカの残りの地域
中近東・アフリカ
トルコ
サウジアラビア
UAE
MEAの残りの地域


ページTOPに戻る


目次

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Treatment for Genito-Urinary Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market by Application
1.3.1 Global Treatment for Genito-Urinary Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Treatment for Genito-Urinary Market Perspective (2017-2028)
2.2 Treatment for Genito-Urinary Growth Trends by Region
2.2.1 Treatment for Genito-Urinary Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Treatment for Genito-Urinary Historic Market Size by Region (2017-2022)
2.2.3 Treatment for Genito-Urinary Forecasted Market Size by Region (2023-2028)
2.3 Treatment for Genito-Urinary Market Dynamics
2.3.1 Treatment for Genito-Urinary Industry Trends
2.3.2 Treatment for Genito-Urinary Market Drivers
2.3.3 Treatment for Genito-Urinary Market Challenges
2.3.4 Treatment for Genito-Urinary Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Treatment for Genito-Urinary Players by Revenue
3.1.1 Global Top Treatment for Genito-Urinary Players by Revenue (2017-2022)
3.1.2 Global Treatment for Genito-Urinary Revenue Market Share by Players (2017-2022)
3.2 Global Treatment for Genito-Urinary Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Treatment for Genito-Urinary Revenue
3.4 Global Treatment for Genito-Urinary Market Concentration Ratio
3.4.1 Global Treatment for Genito-Urinary Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Treatment for Genito-Urinary Revenue in 2021
3.5 Treatment for Genito-Urinary Key Players Head office and Area Served
3.6 Key Players Treatment for Genito-Urinary Product Solution and Service
3.7 Date of Enter into Treatment for Genito-Urinary Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Treatment for Genito-Urinary Breakdown Data by Type
4.1 Global Treatment for Genito-Urinary Historic Market Size by Type (2017-2022)
4.2 Global Treatment for Genito-Urinary Forecasted Market Size by Type (2023-2028)
5 Treatment for Genito-Urinary Breakdown Data by Application
5.1 Global Treatment for Genito-Urinary Historic Market Size by Application (2017-2022)
5.2 Global Treatment for Genito-Urinary Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Treatment for Genito-Urinary Market Size (2017-2028)
6.2 North America Treatment for Genito-Urinary Market Size by Type
6.2.1 North America Treatment for Genito-Urinary Market Size by Type (2017-2022)
6.2.2 North America Treatment for Genito-Urinary Market Size by Type (2023-2028)
6.2.3 North America Treatment for Genito-Urinary Market Share by Type (2017-2028)
6.3 North America Treatment for Genito-Urinary Market Size by Application
6.3.1 North America Treatment for Genito-Urinary Market Size by Application (2017-2022)
6.3.2 North America Treatment for Genito-Urinary Market Size by Application (2023-2028)
6.3.3 North America Treatment for Genito-Urinary Market Share by Application (2017-2028)
6.4 North America Treatment for Genito-Urinary Market Size by Country
6.4.1 North America Treatment for Genito-Urinary Market Size by Country (2017-2022)
6.4.2 North America Treatment for Genito-Urinary Market Size by Country (2023-2028)
6.4.3 the United States
6.4.4 Canada
7 Europe
7.1 Europe Treatment for Genito-Urinary Market Size (2017-2028)
7.2 Europe Treatment for Genito-Urinary Market Size by Type
7.2.1 Europe Treatment for Genito-Urinary Market Size by Type (2017-2022)
7.2.2 Europe Treatment for Genito-Urinary Market Size by Type (2023-2028)
7.2.3 Europe Treatment for Genito-Urinary Market Share by Type (2017-2028)
7.3 Europe Treatment for Genito-Urinary Market Size by Application
7.3.1 Europe Treatment for Genito-Urinary Market Size by Application (2017-2022)
7.3.2 Europe Treatment for Genito-Urinary Market Size by Application (2023-2028)
7.3.3 Europe Treatment for Genito-Urinary Market Share by Application (2017-2028)
7.4 Europe Treatment for Genito-Urinary Market Size by Country
7.4.1 Europe Treatment for Genito-Urinary Market Size by Country (2017-2022)
7.4.2 Europe Treatment for Genito-Urinary Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Treatment for Genito-Urinary Market Size (2017-2028)
8.2 Asia-Pacific Treatment for Genito-Urinary Market Size by Type
8.2.1 Asia-Pacific Treatment for Genito-Urinary Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Treatment for Genito-Urinary Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Treatment for Genito-Urinary Market Share by Type (2017-2028)
8.3 Asia-Pacific Treatment for Genito-Urinary Market Size by Application
8.3.1 Asia-Pacific Treatment for Genito-Urinary Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Treatment for Genito-Urinary Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Treatment for Genito-Urinary Market Share by Application (2017-2028)
8.4 Asia-Pacific Treatment for Genito-Urinary Market Size by Region
8.4.1 Asia-Pacific Treatment for Genito-Urinary Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Treatment for Genito-Urinary Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Treatment for Genito-Urinary Market Size (2017-2028)
9.2 Latin America Treatment for Genito-Urinary Market Size by Type
9.2.1 Latin America Treatment for Genito-Urinary Market Size by Type (2017-2022)
9.2.2 Latin America Treatment for Genito-Urinary Market Size by Type (2023-2028)
9.2.3 Latin America Treatment for Genito-Urinary Market Share by Type (2017-2028)
9.3 Latin America Treatment for Genito-Urinary Market Size by Application
9.3.1 Latin America Treatment for Genito-Urinary Market Size by Application (2017-2022)
9.3.2 Latin America Treatment for Genito-Urinary Market Size by Application (2023-2028)
9.3.3 Latin America Treatment for Genito-Urinary Market Share by Application (2017-2028)
9.4 Latin America Treatment for Genito-Urinary Market Size by Country
9.4.1 Latin America Treatment for Genito-Urinary Market Size by Country (2017-2022)
9.4.2 Latin America Treatment for Genito-Urinary Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Treatment for Genito-Urinary Market Size (2017-2028)
10.2 Middle East & Africa Treatment for Genito-Urinary Market Size by Type
10.2.1 Middle East & Africa Treatment for Genito-Urinary Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Treatment for Genito-Urinary Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Treatment for Genito-Urinary Market Share by Type (2017-2028)
10.3 Middle East & Africa Treatment for Genito-Urinary Market Size by Application
10.3.1 Middle East & Africa Treatment for Genito-Urinary Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Treatment for Genito-Urinary Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Treatment for Genito-Urinary Market Share by Application (2017-2028)
10.4 Middle East & Africa Treatment for Genito-Urinary Market Size by Country
10.4.1 Middle East & Africa Treatment for Genito-Urinary Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Treatment for Genito-Urinary Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Daiichi Sankyo Company
11.1.1 Daiichi Sankyo Company Company Details
11.1.2 Daiichi Sankyo Company Business Overview
11.1.3 Daiichi Sankyo Company Treatment for Genito-Urinary Introduction
11.1.4 Daiichi Sankyo Company Revenue in Treatment for Genito-Urinary Business (2017-2022)
11.1.5 Daiichi Sankyo Company Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Treatment for Genito-Urinary Introduction
11.2.4 Pfizer Revenue in Treatment for Genito-Urinary Business (2017-2022)
11.2.5 Pfizer Recent Developments
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Treatment for Genito-Urinary Introduction
11.3.4 Bayer Revenue in Treatment for Genito-Urinary Business (2017-2022)
11.3.5 Bayer Recent Developments
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Details
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Treatment for Genito-Urinary Introduction
11.4.4 Astellas Pharma Revenue in Treatment for Genito-Urinary Business (2017-2022)
11.4.5 Astellas Pharma Recent Developments
11.5 Allergan
11.5.1 Allergan Company Details
11.5.2 Allergan Business Overview
11.5.3 Allergan Treatment for Genito-Urinary Introduction
11.5.4 Allergan Revenue in Treatment for Genito-Urinary Business (2017-2022)
11.5.5 Allergan Recent Developments
11.6 GSK
11.6.1 GSK Company Details
11.6.2 GSK Business Overview
11.6.3 GSK Treatment for Genito-Urinary Introduction
11.6.4 GSK Revenue in Treatment for Genito-Urinary Business (2017-2022)
11.6.5 GSK Recent Developments
11.7 Otsuka Pharmaceutical
11.7.1 Otsuka Pharmaceutical Company Details
11.7.2 Otsuka Pharmaceutical Business Overview
11.7.3 Otsuka Pharmaceutical Treatment for Genito-Urinary Introduction
11.7.4 Otsuka Pharmaceutical Revenue in Treatment for Genito-Urinary Business (2017-2022)
11.7.5 Otsuka Pharmaceutical Recent Developments
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Treatment for Genito-Urinary Introduction
11.8.4 Sanofi Revenue in Treatment for Genito-Urinary Business (2017-2022)
11.8.5 Sanofi Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

 

ページTOPに戻る


 

Summary

Antibiotic drugs are the basis of urinary tract infection treatment. Antibiotic treatment involves determining the type of bacteria present and choosing the appropriate drug. Antibacterials for urine infections include nalidixic acid, nitrofurantoin, ofloxacin and norfloxacin (for complicated urinary tract infections).
Market Analysis and Insights: Global Treatment for Genito-Urinary Market
The global Treatment for Genito-Urinary market size is projected to reach US$ million by 2028, from US$ million in 2021, at a CAGR of % during 2022-2028.
Fully considering the economic change by this health crisis, OTC accounting for % of the Treatment for Genito-Urinary global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Hospital segment is altered to an % CAGR throughout this forecast period.

China Treatment for Genito-Urinary market size is valued at US$ million in 2021, while the North America and Europe Treatment for Genito-Urinary are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Treatment for Genito-Urinary landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Treatment for Genito-Urinary market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Treatment for Genito-Urinary market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Treatment for Genito-Urinary market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Treatment for Genito-Urinary market.

Global Treatment for Genito-Urinary Scope and Market Size
Treatment for Genito-Urinary market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Treatment for Genito-Urinary market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.

Segment by Type
OTC
Rx Drugs
Segment by Application
Hospital
Drugs Store
Other

By Company
Daiichi Sankyo Company
Pfizer
Bayer
Astellas Pharma
Allergan
GSK
Otsuka Pharmaceutical
Sanofi

By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA



ページTOPに戻る


Table of Contents

1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Treatment for Genito-Urinary Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market by Application
1.3.1 Global Treatment for Genito-Urinary Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Drugs Store
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Treatment for Genito-Urinary Market Perspective (2017-2028)
2.2 Treatment for Genito-Urinary Growth Trends by Region
2.2.1 Treatment for Genito-Urinary Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Treatment for Genito-Urinary Historic Market Size by Region (2017-2022)
2.2.3 Treatment for Genito-Urinary Forecasted Market Size by Region (2023-2028)
2.3 Treatment for Genito-Urinary Market Dynamics
2.3.1 Treatment for Genito-Urinary Industry Trends
2.3.2 Treatment for Genito-Urinary Market Drivers
2.3.3 Treatment for Genito-Urinary Market Challenges
2.3.4 Treatment for Genito-Urinary Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Treatment for Genito-Urinary Players by Revenue
3.1.1 Global Top Treatment for Genito-Urinary Players by Revenue (2017-2022)
3.1.2 Global Treatment for Genito-Urinary Revenue Market Share by Players (2017-2022)
3.2 Global Treatment for Genito-Urinary Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Treatment for Genito-Urinary Revenue
3.4 Global Treatment for Genito-Urinary Market Concentration Ratio
3.4.1 Global Treatment for Genito-Urinary Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Treatment for Genito-Urinary Revenue in 2021
3.5 Treatment for Genito-Urinary Key Players Head office and Area Served
3.6 Key Players Treatment for Genito-Urinary Product Solution and Service
3.7 Date of Enter into Treatment for Genito-Urinary Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Treatment for Genito-Urinary Breakdown Data by Type
4.1 Global Treatment for Genito-Urinary Historic Market Size by Type (2017-2022)
4.2 Global Treatment for Genito-Urinary Forecasted Market Size by Type (2023-2028)
5 Treatment for Genito-Urinary Breakdown Data by Application
5.1 Global Treatment for Genito-Urinary Historic Market Size by Application (2017-2022)
5.2 Global Treatment for Genito-Urinary Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Treatment for Genito-Urinary Market Size (2017-2028)
6.2 North America Treatment for Genito-Urinary Market Size by Type
6.2.1 North America Treatment for Genito-Urinary Market Size by Type (2017-2022)
6.2.2 North America Treatment for Genito-Urinary Market Size by Type (2023-2028)
6.2.3 North America Treatment for Genito-Urinary Market Share by Type (2017-2028)
6.3 North America Treatment for Genito-Urinary Market Size by Application
6.3.1 North America Treatment for Genito-Urinary Market Size by Application (2017-2022)
6.3.2 North America Treatment for Genito-Urinary Market Size by Application (2023-2028)
6.3.3 North America Treatment for Genito-Urinary Market Share by Application (2017-2028)
6.4 North America Treatment for Genito-Urinary Market Size by Country
6.4.1 North America Treatment for Genito-Urinary Market Size by Country (2017-2022)
6.4.2 North America Treatment for Genito-Urinary Market Size by Country (2023-2028)
6.4.3 the United States
6.4.4 Canada
7 Europe
7.1 Europe Treatment for Genito-Urinary Market Size (2017-2028)
7.2 Europe Treatment for Genito-Urinary Market Size by Type
7.2.1 Europe Treatment for Genito-Urinary Market Size by Type (2017-2022)
7.2.2 Europe Treatment for Genito-Urinary Market Size by Type (2023-2028)
7.2.3 Europe Treatment for Genito-Urinary Market Share by Type (2017-2028)
7.3 Europe Treatment for Genito-Urinary Market Size by Application
7.3.1 Europe Treatment for Genito-Urinary Market Size by Application (2017-2022)
7.3.2 Europe Treatment for Genito-Urinary Market Size by Application (2023-2028)
7.3.3 Europe Treatment for Genito-Urinary Market Share by Application (2017-2028)
7.4 Europe Treatment for Genito-Urinary Market Size by Country
7.4.1 Europe Treatment for Genito-Urinary Market Size by Country (2017-2022)
7.4.2 Europe Treatment for Genito-Urinary Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Treatment for Genito-Urinary Market Size (2017-2028)
8.2 Asia-Pacific Treatment for Genito-Urinary Market Size by Type
8.2.1 Asia-Pacific Treatment for Genito-Urinary Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Treatment for Genito-Urinary Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Treatment for Genito-Urinary Market Share by Type (2017-2028)
8.3 Asia-Pacific Treatment for Genito-Urinary Market Size by Application
8.3.1 Asia-Pacific Treatment for Genito-Urinary Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Treatment for Genito-Urinary Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Treatment for Genito-Urinary Market Share by Application (2017-2028)
8.4 Asia-Pacific Treatment for Genito-Urinary Market Size by Region
8.4.1 Asia-Pacific Treatment for Genito-Urinary Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Treatment for Genito-Urinary Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Treatment for Genito-Urinary Market Size (2017-2028)
9.2 Latin America Treatment for Genito-Urinary Market Size by Type
9.2.1 Latin America Treatment for Genito-Urinary Market Size by Type (2017-2022)
9.2.2 Latin America Treatment for Genito-Urinary Market Size by Type (2023-2028)
9.2.3 Latin America Treatment for Genito-Urinary Market Share by Type (2017-2028)
9.3 Latin America Treatment for Genito-Urinary Market Size by Application
9.3.1 Latin America Treatment for Genito-Urinary Market Size by Application (2017-2022)
9.3.2 Latin America Treatment for Genito-Urinary Market Size by Application (2023-2028)
9.3.3 Latin America Treatment for Genito-Urinary Market Share by Application (2017-2028)
9.4 Latin America Treatment for Genito-Urinary Market Size by Country
9.4.1 Latin America Treatment for Genito-Urinary Market Size by Country (2017-2022)
9.4.2 Latin America Treatment for Genito-Urinary Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Treatment for Genito-Urinary Market Size (2017-2028)
10.2 Middle East & Africa Treatment for Genito-Urinary Market Size by Type
10.2.1 Middle East & Africa Treatment for Genito-Urinary Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Treatment for Genito-Urinary Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Treatment for Genito-Urinary Market Share by Type (2017-2028)
10.3 Middle East & Africa Treatment for Genito-Urinary Market Size by Application
10.3.1 Middle East & Africa Treatment for Genito-Urinary Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Treatment for Genito-Urinary Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Treatment for Genito-Urinary Market Share by Application (2017-2028)
10.4 Middle East & Africa Treatment for Genito-Urinary Market Size by Country
10.4.1 Middle East & Africa Treatment for Genito-Urinary Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Treatment for Genito-Urinary Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Daiichi Sankyo Company
11.1.1 Daiichi Sankyo Company Company Details
11.1.2 Daiichi Sankyo Company Business Overview
11.1.3 Daiichi Sankyo Company Treatment for Genito-Urinary Introduction
11.1.4 Daiichi Sankyo Company Revenue in Treatment for Genito-Urinary Business (2017-2022)
11.1.5 Daiichi Sankyo Company Recent Developments
11.2 Pfizer
11.2.1 Pfizer Company Details
11.2.2 Pfizer Business Overview
11.2.3 Pfizer Treatment for Genito-Urinary Introduction
11.2.4 Pfizer Revenue in Treatment for Genito-Urinary Business (2017-2022)
11.2.5 Pfizer Recent Developments
11.3 Bayer
11.3.1 Bayer Company Details
11.3.2 Bayer Business Overview
11.3.3 Bayer Treatment for Genito-Urinary Introduction
11.3.4 Bayer Revenue in Treatment for Genito-Urinary Business (2017-2022)
11.3.5 Bayer Recent Developments
11.4 Astellas Pharma
11.4.1 Astellas Pharma Company Details
11.4.2 Astellas Pharma Business Overview
11.4.3 Astellas Pharma Treatment for Genito-Urinary Introduction
11.4.4 Astellas Pharma Revenue in Treatment for Genito-Urinary Business (2017-2022)
11.4.5 Astellas Pharma Recent Developments
11.5 Allergan
11.5.1 Allergan Company Details
11.5.2 Allergan Business Overview
11.5.3 Allergan Treatment for Genito-Urinary Introduction
11.5.4 Allergan Revenue in Treatment for Genito-Urinary Business (2017-2022)
11.5.5 Allergan Recent Developments
11.6 GSK
11.6.1 GSK Company Details
11.6.2 GSK Business Overview
11.6.3 GSK Treatment for Genito-Urinary Introduction
11.6.4 GSK Revenue in Treatment for Genito-Urinary Business (2017-2022)
11.6.5 GSK Recent Developments
11.7 Otsuka Pharmaceutical
11.7.1 Otsuka Pharmaceutical Company Details
11.7.2 Otsuka Pharmaceutical Business Overview
11.7.3 Otsuka Pharmaceutical Treatment for Genito-Urinary Introduction
11.7.4 Otsuka Pharmaceutical Revenue in Treatment for Genito-Urinary Business (2017-2022)
11.7.5 Otsuka Pharmaceutical Recent Developments
11.8 Sanofi
11.8.1 Sanofi Company Details
11.8.2 Sanofi Business Overview
11.8.3 Sanofi Treatment for Genito-Urinary Introduction
11.8.4 Sanofi Revenue in Treatment for Genito-Urinary Business (2017-2022)
11.8.5 Sanofi Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

  • 本レポートと同分野の最新刊レポートはありません。

QYResearch社の分野での最新刊レポート

  • 最新刊レポートはありません。

本レポートと同じKEY WORD()の最新刊レポート

  • 本レポートと同じKEY WORDの最新刊レポートはありません。

よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2025/03/14 10:26

149.35 円

162.52 円

196.23 円

ページTOPに戻る